Medication info
Menoviksan (Memantine Hydrochloride)

Menoviksan (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Korea Nelson Pharmaceutical Co., Ltd.
Appearance
White, rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201902409 · Approved 2019.04.18 · Insurance code 656702040

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Administer this medicine orally once daily at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7) Administer 5mg daily for 7 days. Week 2 (Days 8–14) Administer 10mg daily for 7 days. Week 3 (Days 15–21) Administer 15mg daily for 7 days. From Week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years or above is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As data on the use of memantine in patients with severe hepatic impairment are unavailable, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Korea Nelson Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Moderate Alzheimer's disease
  • severe Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps improve the patient's memory decline and cognitive dysfunction, thereby enhancing the quality of daily life.

How to take

Adult dose

Administer this medicine orally once daily at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7) Administer 5mg daily for 7 days. Week 2 (Days 8–14) Administer 10mg daily for 7 days. Week 3 (Days 15–21) Administer 15mg daily for 7 days. From Week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years or above is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As data on the use of memantine in patients with severe hepatic impairment are unavailable, it is preferable not to administer this medicine.

Precautions

This medicine should not be used by individuals who are allergic to its components. It should also not be administered to patients with severely impaired liver function or severely impaired kidney function. Caution is warranted for individuals with epilepsy or a history of seizures, as well as when used in conjunction with certain medications, due to an increased risk of side effects. Patients with conditions that may alter urinary acidity or recent cardiovascular diseases require special attention. Side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur; if these symptoms worsen, consult a physician. Due to possible interactions with other drugs, particularly those affecting the nervous system, blood pressure medications, and anticoagulants, it is essential to inform healthcare professionals if you are taking these. Women who are pregnant or breastfeeding should carefully weigh the risks and benefits before taking this medication, and it is advisable to discontinue breastfeeding if taking this medicine. It is generally not recommended for use in children or adolescents under 18 years of age as safety and efficacy have not been established. In cases of overdose, central nervous system symptoms or gastrointestinal symptoms may appear; if this occurs, seek medical attention immediately. This medication is used for patients with severe Alzheimer's disease, so it is safer to avoid driving or operating machinery while taking it. Finally, keep this medication out of the reach of children and avoid transferring it to other containers to maintain its quality.

Side effects

  • dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychiatric reactions
Show 22 more
  • balance disorder
  • gait abnormalities
  • seizures
  • heart failure
  • venous thromboembolism/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggressiveness
  • lethargy
  • unconsciousness
  • diplopia
  • restlessness
  • psychosis
  • visual hallucinations

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from exposure to air or moisture. It is best to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White, rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.